LSL Pharma Group Inc. (TSXV:LSL)
Canada
· Delayed Price · Currency is CAD 0.355
-0.010 (-2.74%)
Feb 21, 2025, 4:00 PM EST
LSL Pharma Group Revenue
LSL Pharma Group had revenue of 4.01M CAD in the quarter ending September 30, 2024, with 59.66% growth. This brings the company's revenue in the last twelve months to 15.82M, up 78.60% year-over-year. In the year 2023, LSL Pharma Group had annual revenue of 10.03M with 22.08% growth.
Revenue (ttm)
15.82M
Revenue Growth
+78.60%
P/S Ratio
2.18
Revenue / Employee
138.79K
Employees
114
Market Cap
41.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 10.03M | 1.81M | 22.08% |
| Dec 31, 2022 | 8.21M | -557.15K | -6.35% |
| Dec 31, 2021 | 8.77M | -1.28M | -12.70% |
| Dec 31, 2020 | 10.05M | 5.22M | 108.32% |
| Oct 3, 2020 | 4.82M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.51B |
| dentalcorp Holdings | 1.51B |
| WELL Health Technologies | 957.69M |
| Curaleaf Holdings | 1.83B |
| Sienna Senior Living | 893.16M |
| Trulieve Cannabis | 1.58B |
| Cronos Group | 150.26M |
| Extendicare | 1.42B |